Abstract: A cable assembly may include a cable terminated with a cable termination configured to electrically couple the cable to a first circuit board and a cable carrier adapter comprising mechanical features configured to mechanically couple the cable and the cable termination in a fixed position relative to the cable carrier adapter and physical dimensions substantially similar to that of a second circuit board configured to electrically and mechanically couple to the first circuit board such that the cable carrier adapter is configured to mechanically engage with guiding features of a housing of the first circuit board for mechanically guiding the second circuit board relative to the first circuit board in order to guide the cable carrier adapter relative to the first circuit board to electrically couple the cable to the first circuit board via the cable termination.

Abstract: The circulation assist devices disclosed herein can be used, for example, in methods of decreasing venous pressure in the Fontan circulation. The devices can include an inlet, an outlet, a stator, a rotor, and an impeller driven by rotation of the rotor. In some embodiments, the impeller blade (or blades) can at least partially define a central lumen extending through the device. The device can be coupled to the inferior vena cava and the pulmonary artery. Rotating the impeller blade(s) increases blood velocity through the lumen and causes the outlet pressure to be higher than the inlet pressure. The impeller can be configured such that, when it is stationary, the forward static pressure drop between the inlet and the outlet is minimized. That is, the forward static pressure drop of the device approximates the pressure drop between the inferior vena cava and central pulmonary artery of the unassisted Fontan circulation.

Abstract: A cable assembly may include a cable terminated with a cable termination configured to electrically couple the cable to a first circuit board and a cable carrier adapter comprising mechanical features configured to mechanically couple the cable and the cable termination in a fixed position relative to the cable carrier adapter and physical dimensions substantially similar to that of a second circuit board configured to electrically and mechanically couple to the first circuit board such that the cable carrier adapter is configured to mechanically engage with guiding features of a housing of the first circuit board for mechanically guiding the second circuit board relative to the first circuit board in order to guide the cable carrier adapter relative to the first circuit board to electrically couple the cable to the first circuit board via the cable termination.

Abstract: Methods of separating plant matter are described herein. The methods may include contacting monocotyledonous plant matter with one or more enzymes or one or more organisms expressing one or more enzymes, where the monocotyledonous plant matter includes vascular bundles, pith, and rind. Following the enzymatic treatment, additional processing of the plant matter may be undertaken through mechanical means. The low-intensity mechanical processing may dislodge the pith, rind, and vascular bundles from one another while minimizing energy consumption and potential damage to the plant matter. Further processing may include sorting mechanisms such as mechanical screening or pneumatic air classification. The incorporation of enzymatic treatment prior to mechanical separation may enhance the efficiency and effectiveness of separating the rind, pith, and vascular bundles from one another compared to conventional mechanical separation methods.

Abstract: A device carrier for an information handling system includes a latch, an interface, lights located on a front of the latch, and first and second light pipes. The latch holds the device carrier within the information handling system. The first light pipes are located within the latch, and provide light to the lights located on the front of the latch. The second light pipes are located within the interface and the latch, and provide the light to the first light pipes. The location of the second light pipes enables the same brightness of the light provided to the lights when a long device is inserted within the device carrier as compared to when a short device is inserted within the device carrier.

Abstract: A device carrier for an information handling system includes a latch, an interface, lights located on a front of the latch, and first and second light pipes. The latch holds the device carrier within the information handling system. The first light pipes are located within the latch, and provide light to the lights located on the front of the latch. The second light pipes are located within the interface and the latch, and provide the light to the first light pipes. The location of the second light pipes enables the same brightness of the light provided to the lights when a long device is inserted within the device carrier as compared to when a short device is inserted within the device carrier.

Abstract: The circulation assist devices disclosed herein can be used, for example, in methods of decreasing venous pressure in the Fontan circulation. The devices can include an inlet, an outlet, a stator, a rotor, and an impeller driven by rotation of the rotor. In some embodiments, the impeller blade (or blades) can at least partially define a central lumen extending through the device. The device can be coupled to the inferior vena cava and the pulmonary artery. Rotating the impeller blade(s) increases blood velocity through the lumen and causes the outlet pressure to be higher than the inlet pressure. The impeller can be configured such that, when it is stationary, the forward static pressure drop between the inlet and the outlet is minimized. That is, the forward static pressure drop of the device approximates the pressure drop between the inferior vena cava and central pulmonary artery of the unassisted Fontan circulation.

Abstract: A blood pump (20) includes a stator assembly comprising a motor stator (52), a fluid inlet (24), and a fluid outlet (26). A rotor assembly includes a motor rotor (54) and an impeller (40) rotatable about an axis (44) to move fluid from the inlet (24) to the outlet (26). An outflow sheath (300) directs the flow along the outside of the pump (20).

Abstract: A blood pump (20) includes a stator assembly comprising a motor stator (52), a fluid inlet (24), and a fluid outlet (26). A rotor assembly includes a motor rotor (54) and an impeller (40) rotatable about an axis (44) to move fluid from the inlet (24) to the outlet (26). An outflow sheath (300) directs the flow along the outside of the pump (20).

Abstract: A trace element solution comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium; and at least one component selected from the group comprising a vitamin, a vaccine, a growth stimulant, a dewormer, iron dextran, an antibiotic and a synchronization preparation. The synchronization preparation is a combination of injectable hormonal preparations, inplantable hormonal preparations, intravaginal hormonal preparation and other slow release hormonal preparation. The antibiotics include oral, injectable and implantable therapeutic remedies. The vaccine includes antigens and a combination of antigens and adjuvants. The growth stimulants include zeranol, estradiol, testosterone, progesterone and trenbolone acetate. The dewormer includes macrocyclic lactones, leramizoles, benzimidazoles and salicylanilides. The macrocyclic lactones include doramectin, ivermectin, abamectin and moxidectin.

Abstract: A blood pump (20) includes a stator assembly comprising a motor stator (52), a fluid inlet (24), and a fluid outlet (26). A rotor assembly includes a motor rotor (54) and an impeller (40) rotatable about an axis (44) to move fluid from the inlet (24) to the outlet (26). An outflow sheath (300) directs the flow along the outside of the pump (20).

Abstract: Embodiments of the present invention provide systems and methods for finding individuals within a field. In one embodiment, a configured query is utilized in order to identify a set of appropriate individuals within a field. Information associated with a skill level and a relationship of a requester is found across a set of disparate media outlets. The system assigns a level of skill set and level of relationship of any identified individual to the requester. A ranking of the identified individuals is generated based on the skill set and relationship of any identified individual based on the configured query.

Abstract: Embodiments of the present invention provide systems and methods for finding individuals within a field. In one embodiment, a configured query is utilized in order to identify a set of appropriate individuals within a field. Information associated with a skill level and a relationship of a requester is found across a set of disparate media outlets. The system assigns a level of skill set and level of relationship of any identified individual to the requester. A ranking of the identified individuals is generated based on the skill set and relationship of any identified individual based on the configured query.

Abstract: A trace element solution comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium; and at least one component selected from the group comprising a vitamin, a vaccine, a growth stimulant, a dewormer, iron dextran, an antibiotic and a synchronization preparation. The synchronization preparation is a combination of injectable hormonal preparations, inplantable hormonal preparations, intravaginal hormonal preparation and other slow release hormonal preparation. The antibiotics include oral, injectable and implantable therapeutic remedies. The vaccine includes antigens and a combination of antigens and adjuvants. The growth stimulants include zeranol, estradiol, testosterone, progesterone and trenbolone acetate. The dewormer includes macrocyclic lactones, leramizoles, benzimidazoles and salicylanilides. The macrocyclic lactones include doramectin, ivermectin, abamectin and moxidectin.

Abstract: A blood pump (20) includes a stator assembly comprising a motor stator (52), a fluid inlet (24), and a fluid outlet (26). A rotor assembly includes a motor rotor (54) and an impeller (40) rotatable about an axis (44) to move fluid from the inlet (24) to the outlet (26). An outflow sheath (300) directs the flow along the outside of the pump (20).

Abstract: Embodiments of the present invention include improved shaped catalyst structures containing catalytic material comprised of mixed oxides of vanadium and phosphorus and using such shaped catalyst structures for the production of maleic anhydride.

Abstract: A blood pump (26) includes a stator assembly (122) that includes a motor stator, a fluid inlet (24), and a fluid outlet (26). A rotor assembly (120) includes a motor rotor (54) and an impeller (40) rotatable about an axis (44) to move fluid from the inlet (24) to the outlet (26). A permanent magnet radial bearing (100) supports the rotor assembly for rotation about the axis (44). The radial bearing (100) includes a permanent magnet radial bearing stator (106) fixed to the stator assembly (122) and a permanent magnet radial bearing rotor (108) fixed to the rotor assembly (120). The radial bearing (100) is configured such that the radial bearing stator magnets (106) and the radial bearing rotor magnets (108) are axially offset from each other when the pump is at rest.

Abstract: An energy-storing prosthetic knee includes an upper leg structure and a lower leg structure hingedly connected to the upper leg structure. The lower and upper leg structures move pivotally relative to one another. A fluid actuator is operatively connected to the upper and lower leg structures such that relative pivotal movement of the upper and lower leg structures causes a fluid to flow in a predetermined manner within the fluid actuator. At least two controllable variable fluid flow resisting devices, an accumulator, and a control system are also provided. The control system is actuable to cause storage of the fluid energy for a predetermined length of time and release of the fluid energy at a predetermined time during the gait cycle. Both the storage and release of the fluid energy are variable by action of the control system without physical modification of other components of the prosthetic knee.

Abstract: The invention discloses a trace element solution, which comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium; and at least one component selected from the group comprising a vitamin, a vaccine, a growth stimulant, a dewormer, iron dextran, an antibiotic and a synchronisation preparation. The synchronisation preparation is a combination of injectable hormonal preparations, inplantable hormonal preparations, intravaginal hormonal preparation and other slow release hormonal preparation. The antibiotics include oral, injectable and implantable theurapeutic remedies. The vaccine includes antigens and a combination of antigens and adjuvents. The growth stimulants include zeranol, estradiol, testosterone, progesterone and trenbolone acetate. The dewormer includes macrocydic lactones, leramizoles, benzimidazoles and salicylanilides. The macrocydic lactones include doramectin, ivermectin, abamectin and moxidectin.

Abstract: The invention discloses a trace element solution, which comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium; and at least one component selected from the group comprising a vitamin, a vaccine, a growth stimulant, a dewormer, iron dextran, an antibiotic and a synchronization preparation. The synchronization preparation is a combination of injectable hormonal preparations, inplantable hormonal preparations, intravaginal hormonal preparation and other slow release hormonal preparation. The antibiotics include oral, injectable and implantable theurapeutic remedies. The vaccine includes antigens and a combination of antigens and adjuvents. The growth stimulants include zeranol, estradiol, testosterone, progesterone and trenbolone acetate. The dewormer includes macrocydic lactones, leramizoles, benzimidazoles and salicylanilides. The macrocydic lactones include doramectin, ivermectin, abamectin and moxidectin.